Australia, May 5 -- SFJ Pharma X Inc., owns the trademark (2622575) for 'RETRIG' till Dec. 19, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations.]
Type of Mark: Word
Date of Acceptance: Feb. 24
Registration Advertised: May 4
For further details contact Muzamil Huq Morrison & Foerster LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2622575.
Disclaimer: Curated by HT Syndication....